King N, Hittinger CT, Carroll SB (2003). „Evolution of key cell signaling and adhesion protein families predates animal origins”. Science301 (5631): 361–3. DOI:10.1126/science.1083853. PMID12869759.
Overington JP, Al-Lazikani B, Hopkins AL (December 2006). „How many drug targets are there?”. Nat Rev Drug Discov5 (12): 993–6. DOI:10.1038/nrd2199. PMID17139284.
Re, RN (Apr 2003). „The intracrine hypothesis and intracellular peptide hormone action”. BioEssays25 (4): 401–9. DOI:10.1002/bies.10248. PMID12655647.
Kumar R, Singh VP, Baker KM. "The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab. 2007 May 15. DOI:10.1016/j.tem.2007.05.001PMID17509892.
Fiaschi-Taesch, NM; Stewart, AF (Feb 2003). „Minireview: parathyroid hormone-related protein as an intracrine factor--trafficking mechanisms and functional consequences”. Endocrinology144 (2): 407–11. DOI:10.1210/en.2002-220818. PMID12538599.
Zhang J, Watanabe Y, Yamada S, Urayama A, Kimura R (2002). „Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice”. Life Sci.72 (4–5): 601–7. DOI:10.1016/S0024-3205(02)02268-3. PMID12467901.
Funder JW, Krozowski Z, Myles K, Sato A, Sheppard KE, Young M (1997). „Mineralocorticoid receptors, salt, and hypertension”. Recent Prog Horm Res52: 247–260. PMID9238855.
Frye CA (2009). „Steroids, reproductive endocrine function, and affect. A review”. Minerva Ginecol61 (6): 541–562. PMID19942840.
King N, Hittinger CT, Carroll SB (2003). „Evolution of key cell signaling and adhesion protein families predates animal origins”. Science301 (5631): 361–3. DOI:10.1126/science.1083853. PMID12869759.
Overington JP, Al-Lazikani B, Hopkins AL (December 2006). „How many drug targets are there?”. Nat Rev Drug Discov5 (12): 993–6. DOI:10.1038/nrd2199. PMID17139284.
Re, RN (Apr 2003). „The intracrine hypothesis and intracellular peptide hormone action”. BioEssays25 (4): 401–9. DOI:10.1002/bies.10248. PMID12655647.
Fiaschi-Taesch, NM; Stewart, AF (Feb 2003). „Minireview: parathyroid hormone-related protein as an intracrine factor--trafficking mechanisms and functional consequences”. Endocrinology144 (2): 407–11. DOI:10.1210/en.2002-220818. PMID12538599.
Zhang J, Watanabe Y, Yamada S, Urayama A, Kimura R (2002). „Neuroprotective effect and brain receptor binding of taltirelin, a novel thyrotropin-releasing hormone (TRH) analogue, in transient forebrain ischemia of C57BL/6J mice”. Life Sci.72 (4–5): 601–7. DOI:10.1016/S0024-3205(02)02268-3. PMID12467901.
Miyoshi Y, Tanji Y, Taguchi T, Tamaki Y, Noguchi S: Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women. Clin Cancer Res. 2003 Jun;9(6):2229-33. PMID12796390
Kajta M, Lason W, Bien E, Marszal M: Neuroprotective effects of estrone on NMDA-induced toxicity in primary cultures of rat cortical neurons are independent of estrogen receptors. Pol J Pharmacol. 2002 Nov-Dec;54(6):727-9. PMID12866733
Kumar R, Singh VP, Baker KM. "The intracellular renin-angiotensin system: a new paradigm. Trends Endocrinol Metab. 2007 May 15. DOI:10.1016/j.tem.2007.05.001PMID17509892.